Purchase Order 75D30121P10233
Award Date
1/22/21
Potential Completion Date
5/31/26
Potential Value
$131K
Federal Agency
CDC Pittsburgh
Awardee
Bioreliance Corporation
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Bioreliance Corporation was awarded a firm fixed price purchase order totaling one hundred thirteen thousand one hundred ninety-six dollars and ten cents ($113,196.10) by the Centers for Disease Control and Prevention (CDC) for storage renewal of Vero and MDCK cell banks. To be performed in Atlanta, Georgia, the contract has a period of performance through May 31, 2020 but does not include any set aside designations. As the prime contractor, Bioreliance will provide continued storage of cell...
This federal contract award, valued at $248,779.00, was issued by the Centers for Disease Control and Prevention (CDC) to Bioreliance Corporation, a foreign-owned, for-profit organization, to conduct follow-up testing for tumorigenicity and oncogenicity on the Master Cell Bank (MCB) of Expi293F cells. The contract is a firm-fixed-price purchase order with a completion date of September 24, 2026. The original sources sought notice indicates that the CDC Influenza Division requires cGMP-grade cell...
The Centers for Disease Control and Prevention (CDC) awarded a $249,662 purchase order to Cell Microsystems Inc. to procure cell lines in support of the agency's biomedical research and public health initiatives. The firm fixed price contract has a period of performance from September 11, 2023 through October 30, 2023 for delivery of the requested cell lines to CDC facilities in Durham, North Carolina. No subcontractors or set aside designations were identified. This award advances the CDC's...
This federal contract award is for a Definitive Contract with a Ceiling Value of $410,000.00. The contract was awarded to Bioreliance Corporation, a foreign-owned, for-profit organization that provides specialized testing services to the U.S. government, particularly the Department of Health and Human Services. The contract is for "BIOMEDICAL (BASIC)" services, which primarily include endotoxin, sterility, and general safety testing in support of investigational new drug...
This is a definitive contract award to Bioreliance Corporation, a foreign-owned, for-profit organization, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The $672,262.42 firm-fixed-price contract is for BIORELIANCE EXPI293F services, which likely includes specialized microbiological and scientific testing capabilities to support pharmaceutical and biotechnology research, such as endotoxin testing, sterility testing, and Limulus Amebocyte Lysate (LAL) testing. The...
This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Bioreliance Corporation for $127,772.70. The contract is for biosafety testing of GMP (Good Manufacturing Practice) master cell banks, a critical step in the development of new pharmaceutical products. Bioreliance, a foreign-owned, for-profit company, has extensive experience providing microbiological testing services to federal health...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services (HHS), to Bioreliance Corporation, a foreign-owned, for-profit organization specializing in critical testing services for the pharmaceutical and biotechnology industries. The $4,930.00 firm fixed-price purchase order is for Bioreliance's cell bank storage and other related functions. This award is not designated as a...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to EMD Millipore Corp, a foreign-owned, for-profit manufacturer of laboratory products and services, for maintenance services. The contract has a ceiling value of $7,622.52 and a period of performance running through June 29, 2024. EMD Millipore Corp is a major supplier of specialized equipment, consumables, and services to federal agencies like the NIH, CDC, DoD, and FDA. This includes...
This is a federal contract awarded by the Centers for Disease Control and Prevention (CDC) to the American Type Culture Collection (ATCC), a nonprofit organization that serves as a global biological materials and information resource. The contract has a ceiling value of $264,096,207.24 and a performance period ending on August 30, 2019. It is a definitive contract with a cost-plus-fixed-fee pricing structure, without any set-aside designation. ATCC has an extensive history of supporting...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...